We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ERLYAND, JANSSEN APALUTAMIDE (Janssen-Cilag Pty Ltd)
Product name
ERLYAND, JANSSEN APALUTAMIDE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
218 working days (255)
Active ingredients
apalutamide
Registration type
EOI
Indication
ERLYAND, JANSSEN APALUTAMIDE (film coated tablet) is now also indicated for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC).